Health Utility Value of Overactive Bladder in Japanese Older Adults

Overview

Journal BJUI Compass

Date 2025 Jan 29

PMID 39877574

Authors

Takashi Yoshioka

Kenji Omae

Satoshi Funada

Tetsuji Minami

Rei Goto

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine the health utility values (HUVs) of overactive bladder (OAB), defined as urinary urgency, usually accompanied by urinary daytime or nocturnal frequency, with or without urinary incontinence, among adults aged ≥65 years and to assess the HUV decrements (disutilities) of OAB according to its severity.

Methods: This cross-sectional Internet-based study was conducted between 2 and 9 November 2023, with quota sampling with equal probability for each sex and age group (age 65-74 years and ≥75 years). OAB was defined as an urgency score of ≥2 points and a total score of ≥3 points based on the Overactive Bladder Symptom Score. OAB severity was categorized as mild (total score, ≤5 points) or moderate-to-severe (total score, 6-15 points). HUVs were measured using the EuroQol five-dimension five-level value set for the Japanese population. Multivariable linear regression models were fitted to estimate the covariate-adjusted disutilities of OAB. We selected eight covariates (age, sex, body mass index, education, income, smoking, alcohol use, and comorbidities) as potential confounders based on previous studies. The sample size was determined based on previous studies without statistical power calculations.

Results: Among the 998 participants (51.9% male; mean age, 73.2 years), 158 (15.9%) had OAB, of whom 87 (8.8%) had moderate-to-severe OAB. The mean HUVs for participants with mild and moderate-to-severe OAB were 0.874 and 0.840, respectively, which were lower compared with the HUV for those without OAB (0.913). After adjusting for relevant covariates, disutilities (95% confidence intervals [CIs] and values) for mild and moderate-to-severe OAB were -0.0334 (-0.0602 to -0.0066, = 0.014) and -0.0591 (-0.0844 to -0.0339, < 0.001), respectively.

Conclusions: Consistent with previous HUV studies on OAB, our results demonstrated that the prevalence of OAB was associated with substantially lower HUV. The results demonstrate that increased OAB severity is associated with greater disutility.

References

Kay S, Tolley K, Colayco D, Khalaf K, Anderson P, Globe D . Mapping EQ-5D utility scores from the Incontinence Quality of Life Questionnaire among patients with neurogenic and idiopathic overactive bladder. Value Health. 2013; 16(2):394-402. DOI: 10.1016/j.jval.2012.12.005. View

Gotoh M, Kobayashi T, Sogabe K . Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder. Neurourol Urodyn. 2014; 34(8):730-5. DOI: 10.1002/nau.22663. View

Husereau D, Drummond M, Augustovski F, De Bekker-Grob E, Briggs A, Carswell C . Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Pharmacoeconomics. 2022; 40(6):601-609. PMC: 9130151. DOI: 10.1007/s40273-021-01112-8. View

Kim S, Kim S . The impact of overactive bladder on health-related quality of life in Korea: based on the results of a Korean Community Health Survey. Qual Life Res. 2020; 30(4):1017-1024. DOI: 10.1007/s11136-020-02710-3. View

Welk B, Baverstock R . Is there a link between back pain and urinary symptoms?. Neurourol Urodyn. 2020; 39(2):523-532. DOI: 10.1002/nau.24269. View

Funada S, Kawaguchi T, Terada N, Negoro H, Tabara Y, Kosugi S . Cross-Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations. J Urol. 2017; 199(3):774-778. DOI: 10.1016/j.juro.2017.09.146. View

Eysenbach G . Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004; 6(3):e34. PMC: 1550605. DOI: 10.2196/jmir.6.3.e34. View

Mitsui T, Sekido N, Masumori N, Haga N, Omae K, Saito M . Prevalence and impact on daily life of lower urinary tract symptoms in Japan: Results of the 2023 Japan Community Health Survey (JaCS 2023). Int J Urol. 2024; 31(7):747-754. PMC: 11524089. DOI: 10.1111/iju.15454. View

Lai S, Pastore S, Piloni L, Mangiulli M, Esposito Y, Pierella F . Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients. Clin Kidney J. 2019; 12(3):414-419. PMC: 6543956. DOI: 10.1093/ckj/sfy085. View

10.

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M . Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology. 2006; 68(2):318-23. DOI: 10.1016/j.urology.2006.02.042. View

11.

Chang E, Saigal C, Raldow A . Explaining Health State Utility Assessment. JAMA. 2020; 323(11):1085-1086. DOI: 10.1001/jama.2020.0656. View

12.

Milsom I, Coyne K, Nicholson S, Kvasz M, Chen C, Wein A . Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2013; 65(1):79-95. DOI: 10.1016/j.eururo.2013.08.031. View

13.

Keam S . Vibegron: First Global Approval. Drugs. 2018; 78(17):1835-1839. DOI: 10.1007/s40265-018-1006-3. View

14.

Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R . A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019; 75(6):988-1000. DOI: 10.1016/j.eururo.2019.02.038. View

15.

Omae K, Kurita N, Takeshima T, Naganuma T, Takahashi S, Yoshioka T . Significance of Overactive Bladder as a Predictor of Falls in Community Dwelling Older Adults: 1-Year Followup of the Sukagawa Study. J Urol. 2020; 205(1):219-225. DOI: 10.1097/JU.0000000000001344. View

16.

Coyne K, Sexton C, Vats V, Thompson C, Kopp Z, Milsom I . National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011; 77(5):1081-7. DOI: 10.1016/j.urology.2010.08.039. View

17.

Funada S, Luo Y, Uozumi R, Watanabe N, Goto T, Negoro H . Multicomponent Intervention for Overactive Bladder in Women: A Randomized Clinical Trial. JAMA Netw Open. 2024; 7(3):e241784. PMC: 10938174. DOI: 10.1001/jamanetworkopen.2024.1784. View

18.

Kelfve S, Kivi M, Johansson B, Lindwall M . Going web or staying paper? The use of web-surveys among older people. BMC Med Res Methodol. 2020; 20(1):252. PMC: 7545880. DOI: 10.1186/s12874-020-01138-0. View

19.

Shiroiwa T, Noto S, Fukuda T . Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings. Value Health. 2021; 24(8):1193-1202. DOI: 10.1016/j.jval.2021.03.010. View

20.

Wailoo A, Alava M, Pudney S, Barton G, ODwyer J, Gomes M . An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis. Value Health. 2021; 24(4):568-574. DOI: 10.1016/j.jval.2020.11.012. View